Expansion will bring total headcount to 1,400 at Regeneron’s campus in Limerick.
Biopharma giant Regeneron is to add more than 400 jobs at its Limerick campus to as part of its global ram-up to defeat Covid-19.
The company is maximising manufacturing capacity at its New York facility for REGN-COV2, Regeneron’s investigational two-antibody combination being developed for the potential treatment and prevention of Covid-19 infection.
“You can only perform like this if you have good people, and Ireland has lots of good people, so we are excited to be hiring 400 more”
The creation of more than 400 new jobs is part of Regeneron’s long-term commitment to Ireland and the Limerick community.
“As this pandemic hit, we needed to quickly change how we do things and where we make our products. In order to make space in our New York facilities to accommodate our Covid-19 efforts, we needed to ramp-up capacity here in Limerick,” said Dan Van Plew, executive vice-president and general manager of Industrial Operations and Product Supply (IOPS) at Regeneron.
“Despite ramping up commercial production sooner than planned, my team hasn’t missed a beat. You can only perform like this if you have good people, and Ireland has lots of good people, so we are excited to be hiring 400 more.”
“Just six years ago, we hired our first employee in Limerick,” said Niall O’Leary, vice-president and site head for IOPS in Limerick.
“Today, we have more than 1,000 full-time employees at our Limerick campus and with this latest announcement we are adding an additional 400 people to our world-class team. This demonstrates not only Regeneron’s incredibly strong pipeline but our commitment to Ireland and the Mid-West region. I am very proud of what our team has achieved and continue to be impressed with the calibre of talent here.”
Since 2014, Regeneron has invested over $1bn to build the largest bulk biologics production facility in the country, with over 1,000 employees, more than 300 contingent workers and close to 500 construction personnel currently working on site.
“This significant jobs announcement by Regeneron is a further vote of confidence in the skills and talent of our workforce and provides a welcome boost to our economy,” said Taoieach Micheál Martin, TD. “Ireland continues to resonate with leading global companies for investment. The government’s mission over the coming months and years is to rebuild our society and economy in the post-Covid world. We need to get people back to work and to protect and create sustainable jobs. This announcement is an important and welcome step in that journey.”
Recruitment is underway to hire full-time, high-end specialist jobs in commercial manufacturing, process sciences, quality assurance/control, supply chain and various support functions for scientists, chemists and technicians.
“The addition of 400 highly skilled roles by Regeneron at its Limerick campus is a huge boost for Ireland and the Mid-West region,” said Mary Buckley, executive director of IDA Ireland.
“The company has expanded rapidly since it first chose to locate in Limerick. This significant job announcement by Regeneron in a regional location is very welcome and points to Ireland’s reputation as a global location of excellence for biopharmaceuticals. I wish the team continued success as they welcome 400 new colleagues to the site in the coming months.”
Written by John Kennedy (email@example.com)
Published: 27 August, 2020